Oral and fecal microbiota perturbance in cocaine users: Can rTMS-induced cocaine abstinence support eubiosis restoration?

Microbiome Substance of abuse

Journal

iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038

Informations de publication

Date de publication:
19 May 2023
Historique:
received: 16 01 2023
revised: 09 03 2023
accepted: 31 03 2023
medline: 30 5 2023
pubmed: 30 5 2023
entrez: 30 5 2023
Statut: epublish

Résumé

The effects of cocaine on microbiota have been scarcely explored. Here, we investigated the gut (GM) and oral (OM) microbiota composition of cocaine use disorder (CUD) patients and the effects of repetitive transcranial magnetic stimulation (rTMS). 16S rRNA sequencing was used to characterize GM and OM, whereas PICRUST2 assessed functional changes in microbial communities, and gas-chromatography was used to evaluate fecal short and medium chain fatty acids. CUD patients reported a significant decrease in alpha diversity and modification of the abundances of several taxa in both GM and OM. Furthermore, many predicted metabolic pathways were differentially expressed in CUD patients' stool and saliva samples, as well as reduced levels of butyric acid that appear restored to normal amounts after rTMS treatment. In conclusion, CUD patients showed a profound dysbiotic fecal and oral microbiota composition and function and rTMS-induced cocaine abstinence determined the restoration of eubiotic microbiota.

Identifiants

pubmed: 37250301
doi: 10.1016/j.isci.2023.106627
pii: S2589-0042(23)00704-6
pmc: PMC10214473
doi:

Types de publication

Journal Article

Langues

eng

Pagination

106627

Informations de copyright

© 2023 The Author(s).

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Références

J Neuroinflammation. 2019 Dec 5;16(1):255
pubmed: 31805953
World J Gastroenterol. 2019 Sep 28;25(36):5543-5558
pubmed: 31576099
Front Cell Infect Microbiol. 2021 Sep 10;11:706961
pubmed: 34568092
PLoS One. 2015 Dec 03;10(12):e0144270
pubmed: 26633823
Prog Neuropsychopharmacol Biol Psychiatry. 2022 Jun 8;116:110513
pubmed: 35074451
Acta Gastroenterol Belg. 2020 Oct-Dec;83(4):616-621
pubmed: 33321019
Int J Mol Sci. 2021 Apr 29;22(9):
pubmed: 33946648
Front Immunol. 2019 Oct 15;10:2435
pubmed: 31749792
Mucosal Immunol. 2016 Nov;9(6):1418-1428
pubmed: 26906406
J Neuroimmune Pharmacol. 2022 Jun;17(1-2):33-61
pubmed: 34694571
Dent J (Basel). 2021 Jun 17;9(6):
pubmed: 34204219
Biomed Pharmacother. 2019 Jul;115:108945
pubmed: 31100541
Front Psychiatry. 2011 Nov 29;2:64
pubmed: 22144966
Chem Res Toxicol. 2017 Dec 18;30(12):2110-2119
pubmed: 29035044
Nat Rev Immunol. 2017 Apr;17(4):219-232
pubmed: 28260787
Pharmacol Rev. 2021 Apr;73(2):571-596
pubmed: 33597276
Ann Clin Transl Neurol. 2021 Dec;8(12):2252-2269
pubmed: 34889081
Lab Invest. 2013 Jul;93(7):834-43
pubmed: 23752130
J Oral Microbiol. 2016 Sep 26;8:32762
pubmed: 27677454
Alcohol Res. 2015;37(2):223-36
pubmed: 26695747
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):E4485-93
pubmed: 25288760
PLoS One. 2014 Sep 25;9(9):e106111
pubmed: 25254365
Front Neuroendocrinol. 2021 Jul;62:100917
pubmed: 33957173
Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jul 13;85:105-115
pubmed: 29705711
Biol Psychiatry Cogn Neurosci Neuroimaging. 2021 Jul;6(7):745-757
pubmed: 33508499
PLoS One. 2013 Apr 22;8(4):e61217
pubmed: 23630581
Pathogens. 2019 May 01;8(2):
pubmed: 31052371
Nucleic Acids Res. 2018 Jul 2;46(W1):W537-W544
pubmed: 29790989
EBioMedicine. 2020 May;55:102769
pubmed: 32403084
PLoS One. 2020 Jan 24;15(1):e0227774
pubmed: 31978078
Ann Gastroenterol. 2015 Apr-Jun;28(2):203-209
pubmed: 25830558
J Oral Microbiol. 2021 Dec 01;14(1):2004790
pubmed: 34880965
Int J Mol Sci. 2020 Jul 08;21(14):
pubmed: 32650553
Sci Rep. 2017 Jun 15;7(1):3628
pubmed: 28620208
Nat Rev Gastroenterol Hepatol. 2019 Aug;16(8):461-478
pubmed: 31123355
Genome Biol. 2014;15(12):550
pubmed: 25516281
Neurosci Lett. 2016 Jun 20;625:56-63
pubmed: 26868600
Microb Pathog. 2016 May;94:27-34
pubmed: 26416306
Front Endocrinol (Lausanne). 2020 Jan 31;11:25
pubmed: 32082260
Front Cell Neurosci. 2021 Apr 14;15:633735
pubmed: 33935651
Toxicol Pathol. 2017 Jan;45(1):150-156
pubmed: 27895265
Sci Rep. 2019 Aug 21;9(1):12187
pubmed: 31434922
Sci Rep. 2020 Sep 25;10(1):15807
pubmed: 32978483
Int J Mol Sci. 2021 Jun 16;22(12):
pubmed: 34208638
Nat Biotechnol. 2020 Jun;38(6):685-688
pubmed: 32483366
Int Rev Neurobiol. 2005;63:101-54
pubmed: 15797467
Microbiol Spectr. 2021 Oct 31;9(2):e0070121
pubmed: 34585987
PLoS One. 2020 Mar 23;15(3):e0227044
pubmed: 32203565
Psychopharmacology (Berl). 2012 Feb;219(4):933-44
pubmed: 21809009
J Neuroimmune Pharmacol. 2022 Jun;17(1-2):305-317
pubmed: 34448131
Front Microbiol. 2022 Sep 26;13:999001
pubmed: 36225386
Int J Dev Neurosci. 2003 Oct;21(6):327-32
pubmed: 12927581
PLoS One. 2021 Nov 16;16(11):e0259860
pubmed: 34784373
Curr Opin Endocrinol Diabetes Obes. 2017 Feb;24(1):9-14
pubmed: 27820704
J Physiol. 2018 Oct;596(20):4923-4944
pubmed: 30066368
Brain Res Mol Brain Res. 2005 Dec 7;142(1):28-38
pubmed: 16219387
J Neurochem. 2021 Jun;157(5):1495-1524
pubmed: 33368280
J Stud Alcohol Drugs. 2014 Mar;75(2):347-57
pubmed: 24650829
Alcohol Alcohol. 2017 Jul 01;52(4):403-413
pubmed: 28482009
Clin Neurophysiol. 2014 Nov;125(11):2150-2206
pubmed: 25034472
Brain Res. 2018 Aug 15;1693(Pt B):128-133
pubmed: 29903615
Front Neurosci. 2022 Feb 02;16:820106
pubmed: 35185459
Med Oral Patol Oral Cir Bucal. 2013 Jul 01;18(4):e671-9
pubmed: 23722124
Neurotox Res. 2010 May;17(4):392-8
pubmed: 19763733
Neuropsychopharmacology. 2018 Dec;43(13):2606-2614
pubmed: 30258112
Front Psychiatry. 2018 Mar 16;9:80
pubmed: 29615935
Hypertension. 2018 Nov;72(5):1012-1022
pubmed: 30354823
Nutrients. 2019 Jan 12;11(1):
pubmed: 30642052
Neurotox Res. 2019 Jan;35(1):111-121
pubmed: 30066173
Microbiome. 2018 Apr 24;6(1):59
pubmed: 29685174
Front Physiol. 2019 Jun 04;10:657
pubmed: 31214043
Brain Behav Immun. 2019 Nov;82:25-35
pubmed: 31356922
Aliment Pharmacol Ther. 2017 Jan;45(2):319-331
pubmed: 27868217
Psychiatry Res. 2018 Nov;269:126-133
pubmed: 30145293
Drug Alcohol Depend. 2008 May 1;95(1-2):30-6
pubmed: 18243579
Front Microbiol. 2022 Feb 04;12:737197
pubmed: 35185808
Bioinformatics. 2015 Nov 15;31(22):3718-20
pubmed: 26209431
PeerJ. 2016 Oct 18;4:e2584
pubmed: 27781170
Adv Ther. 2020 Apr;37(4):1328-1346
pubmed: 32130662
Front Pharmacol. 2021 Aug 20;12:699026
pubmed: 34489696
Int J Neuropsychopharmacol. 2014 Oct 31;18(2):
pubmed: 25618518
Front Microbiol. 2017 Aug 25;8:1620
pubmed: 28890714
Nutr Metab (Lond). 2018 May 3;15:33
pubmed: 29755574
Gut Microbes. 2019;10(6):663-675
pubmed: 30894059
Genome Biol. 2011 Jun 24;12(6):R60
pubmed: 21702898
Behav Brain Res. 2019 Dec 30;376:112196
pubmed: 31476330
J Neuroimmune Pharmacol. 2019 Jun;14(2):200-214
pubmed: 30242614
Brain Res. 2016 Jul 1;1642:70-78
pubmed: 27017959
Front Endocrinol (Lausanne). 2021 Jun 08;12:667066
pubmed: 34168615
J R Soc Med. 2006 Feb;99(2):51-2
pubmed: 16449766
Hum Psychopharmacol. 2012 Mar;27(2):156-66
pubmed: 22389080
Microorganisms. 2021 Sep 30;9(10):
pubmed: 34683389
J Med Microbiol. 2001 Nov;50(11):940-946
pubmed: 11699589
Front Psychiatry. 2019 Sep 05;10:621
pubmed: 31543838
Front Neurosci. 2020 Mar 06;14:137
pubmed: 32210744
Sci Adv. 2019 Oct 16;5(10):eaax1532
pubmed: 31663022
Oral Dis. 2021 Jul;27(5):1073-1089
pubmed: 32390250
Sci Rep. 2016 Oct 18;6:35455
pubmed: 27752130
Syst Biol. 2019 Mar 1;68(2):365-369
pubmed: 30165689
Psychopharmacology (Berl). 2019 May;236(5):1513-1530
pubmed: 30982128
Nat Biotechnol. 2019 Aug;37(8):852-857
pubmed: 31341288
Front Psychiatry. 2022 Mar 30;13:810008
pubmed: 35432038
Environ Microbiol. 2016 May;18(5):1352-63
pubmed: 26033517
Gut Microbes. 2021 Jan-Dec;13(1):1946368
pubmed: 34313547
Neurophysiol Clin. 2019 Feb;49(1):1-9
pubmed: 30712533
Front Microbiol. 2021 Oct 06;12:738401
pubmed: 34690981

Auteurs

Elisabetta Gerace (E)

Department of Neuroscience, Psychology, Drug Research and Child Health NEUROFARBA, University of Florence, 50139 Florence, Italy.
Department of Health Sciences, Clinical Pharmacology and Oncology Unit, University of Florence, 50139 Florence, Italy.

Simone Baldi (S)

Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy.

Maya Salimova (M)

Azienda Ospedaliera Universitaria di Careggi, Clinical Toxicology and Poison Control Centre, 50134 Florence, Italy.

Leandro Di Gloria (L)

Department of Biomedical, Experimental and Clinical Sciences "Mario Serio", University of Florence, 50134 Florence, Italy.

Lavinia Curini (L)

Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy.

Virginia Cimino (V)

Department of Neuroscience, Psychology, Drug Research and Child Health NEUROFARBA, University of Florence, 50139 Florence, Italy.

Giulia Nannini (G)

Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy.

Edda Russo (E)

Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy.

Marco Pallecchi (M)

Department of Neuroscience, Psychology, Drug Research and Child Health NEUROFARBA, University of Florence, 50139 Florence, Italy.

Matteo Ramazzotti (M)

Department of Biomedical, Experimental and Clinical Sciences "Mario Serio", University of Florence, 50134 Florence, Italy.

Gianluca Bartolucci (G)

Department of Neuroscience, Psychology, Drug Research and Child Health NEUROFARBA, University of Florence, 50139 Florence, Italy.

Brunella Occupati (B)

Azienda Ospedaliera Universitaria di Careggi, Clinical Toxicology and Poison Control Centre, 50134 Florence, Italy.

Cecilia Lanzi (C)

Azienda Ospedaliera Universitaria di Careggi, Clinical Toxicology and Poison Control Centre, 50134 Florence, Italy.

Maenia Scarpino (M)

Azienda Ospedaliera Universitaria di Careggi, Neurophysiology Unit, 50134 Florence, Italy.

Giovanni Lanzo (G)

Azienda Ospedaliera Universitaria di Careggi, Neurophysiology Unit, 50134 Florence, Italy.

Antonello Grippo (A)

Azienda Ospedaliera Universitaria di Careggi, Neurophysiology Unit, 50134 Florence, Italy.

Francesco Lolli (F)

Department of Biomedical, Experimental and Clinical Sciences "Mario Serio", University of Florence, 50134 Florence, Italy.

Guido Mannaioni (G)

Department of Neuroscience, Psychology, Drug Research and Child Health NEUROFARBA, University of Florence, 50139 Florence, Italy.
Azienda Ospedaliera Universitaria di Careggi, Clinical Toxicology and Poison Control Centre, 50134 Florence, Italy.

Amedeo Amedei (A)

Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy.
Interdisciplinary Internal Medicine Unit, Careggi University Hospital, 50134 Florence, Italy.

Classifications MeSH